FI892067A0 - Gabapentinmonohydrat och foerfarande foer framstaellning daerav. - Google Patents

Gabapentinmonohydrat och foerfarande foer framstaellning daerav.

Info

Publication number
FI892067A0
FI892067A0 FI892067A FI892067A FI892067A0 FI 892067 A0 FI892067 A0 FI 892067A0 FI 892067 A FI892067 A FI 892067A FI 892067 A FI892067 A FI 892067A FI 892067 A0 FI892067 A0 FI 892067A0
Authority
FI
Finland
Prior art keywords
gabapentinmonohydrat
foerfarande foer
foer framstaellning
och foerfarande
framstaellning daerav
Prior art date
Application number
FI892067A
Other languages
English (en)
Other versions
FI892067A (fi
Inventor
Donald Eugene Butler
Barbara Jean Greenman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22694659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI892067(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI892067A0 publication Critical patent/FI892067A0/fi
Publication of FI892067A publication Critical patent/FI892067A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI892067A 1988-05-02 1989-04-28 Gabapentinmonohydrat och foerfarande foer framstaellning daerav. FI892067A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/188,819 US4894476A (en) 1988-05-02 1988-05-02 Gabapentin monohydrate and a process for producing the same

Publications (2)

Publication Number Publication Date
FI892067A0 true FI892067A0 (fi) 1989-04-28
FI892067A FI892067A (fi) 1989-11-03

Family

ID=22694659

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892067A FI892067A (fi) 1988-05-02 1989-04-28 Gabapentinmonohydrat och foerfarande foer framstaellning daerav.

Country Status (12)

Country Link
US (1) US4894476A (fi)
EP (1) EP0340677B1 (fi)
JP (1) JP2619951B2 (fi)
AT (1) ATE101116T1 (fi)
AU (1) AU624130B2 (fi)
CA (1) CA1306755C (fi)
DE (1) DE68912819T2 (fi)
DK (1) DK175400B1 (fi)
ES (1) ES2061774T3 (fi)
FI (1) FI892067A (fi)
HK (1) HK1000798A1 (fi)
IE (1) IE62958B1 (fi)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928183A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
PH27359A (en) * 1989-08-25 1993-06-21 Warner Lambert Co Process for cyclic amino acid anticonvulsant compounds
DE3928184A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
DE3928182A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von gabapentin
EP0458751A1 (en) * 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
BR9708200A (pt) * 1996-03-14 1999-07-27 Warner Lambert Co Aminoácidos cíclicos substituídos como agentes farmacéuticos
US6372792B1 (en) 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
US6255526B1 (en) 1996-12-24 2001-07-03 Teva Pharmaceutical Industries Ltd. Preparation of gabapentin
WO1999018063A2 (en) 1997-10-07 1999-04-15 Warner-Lambert Company Process for preparing a cyclic amino acid anticonvulsant compound
ES2137137B1 (es) 1998-05-25 2000-08-16 Medichem Sa Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
ITMI981535A1 (it) * 1998-07-03 2000-01-03 Zambon Spa Processo per la preparazione di gabapentina
HU225502B1 (en) * 1998-12-29 2007-01-29 Richter Gedeon Vegyeszet Process for producing 1-(amino-metyl)-cyclohexene-acetic-acid and intermediates
IT1311984B1 (it) 1999-03-26 2002-03-22 Bioindustria Lab Italiano Medi Procedimento per la preparzione di gabapentin.
EP1169060B1 (en) * 1999-04-09 2005-08-31 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
ES2164527B1 (es) * 1999-04-26 2003-04-01 Medichen S A Procedimiento de obtencion de gabapentina de calidad farmaceutica.
US6294198B1 (en) 1999-08-24 2001-09-25 Purepac Pharmaceutical Co. Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
US6333352B1 (en) 2000-04-05 2001-12-25 Mimicking Man Manually, Inc. Method of treating benign positional vertigo
WO2001097612A1 (en) * 2000-06-16 2001-12-27 Teva Pharmaceutical Industries Ltd. Stable gabapentin containing more than 2o ppm of chlorine ion
AU2001266992B8 (en) * 2000-06-16 2005-12-01 Teva Pharmaceutical Industries Ltd. Stable gabapentin having pH within a controlled range
EP1384473A1 (en) * 2000-06-16 2004-01-28 Teva Pharmaceutical Industries Ltd. Stable gabapentin containing more than 20 ppm of chlorine ion
ITMI20011132A1 (it) 2001-05-29 2002-11-29 Procos Spa Procedimento per la preparazione dell'acido 1-amminometil-1-cicloesanacetico
PT1423168E (pt) * 2001-09-03 2006-05-31 Newron Pharm Spa Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
US6800782B2 (en) * 2001-10-09 2004-10-05 Warner-Lambert Co. Anhydrous crystalline forms of gabapentin
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US20070184104A1 (en) * 2001-10-25 2007-08-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
US6682759B2 (en) 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
CN1649600A (zh) 2002-02-28 2005-08-03 A&D生物科学公司 氟西汀及类似物的糖醛酰胺、苷和原酸酯苷及其应用
WO2003079980A2 (en) * 2002-03-19 2003-10-02 A & D Bioscience, Inc. Caboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
US20050255038A1 (en) * 2002-04-12 2005-11-17 A And D Bioscience, Inc. Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof
US20040034248A1 (en) * 2002-04-16 2004-02-19 Taro Pharmaceutical Industries, Ltd. Process for preparing gabapentin
WO2003094842A2 (en) * 2002-05-07 2003-11-20 A & D Bioscience, Inc. Conjugates comprising central nervous system active drug
US20050215487A1 (en) * 2002-06-27 2005-09-29 Holick Michael F Conjugates comprising an nsaid and a sugar and uses thereof
AU2002356424A1 (en) * 2002-11-18 2004-06-15 Nicholas Piramal India Limited Improved process for preparation of gabapentin
US20040214893A1 (en) * 2003-04-11 2004-10-28 Matthew Peterson Gabapentin compositions
WO2004093780A2 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of gabapentin form-ii
US20070043236A1 (en) * 2003-05-19 2007-02-22 Chandiran Thakashina M Process for preparation of gabapentin
WO2004106281A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Crystalline gabapentin
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
US20050187295A1 (en) * 2004-02-19 2005-08-25 Surendra Kalyan Processes for the preparation of gabapentin
ITMI20040579A1 (it) * 2004-03-25 2004-06-25 Zambon Spa Processo di preparazione di gabapentina
GB0416228D0 (en) 2004-07-20 2004-08-25 Sandoz Ind Products S A Process for the preparation of gabapentin
KR101277520B1 (ko) * 2004-09-10 2013-06-21 뉴론 파마슈티칼즈 에스. 피. 에이. （할로벤질옥시）벤질아미노－프로판아미드를 포함하는 선택적 나트륨 및／또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
ITMI20042418A1 (it) * 2004-12-17 2005-03-17 Zambon Spa Processo per la purificazione della gabapentina
US7071356B1 (en) * 2005-12-01 2006-07-04 Isp Investments Inc. Process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid
US20090176882A1 (en) * 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
WO2009139470A1 (ja) * 2008-05-16 2009-11-19 学校法人聖マリアンナ医科大学 線維筋痛症治療用医薬組成物
US8431739B2 (en) 2010-06-14 2013-04-30 Divi's Laboratories, Ltd. Process for the preparation of gabapentin
EP2923694B1 (en) 2014-03-27 2018-11-14 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical solution of gabapentin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4014175A (en) * 1975-05-05 1977-03-29 Brink Douglas F Cable and pipe laying machine
US4087594A (en) * 1977-03-21 1978-05-02 Gte Laboratories, Incorporated Reactivation of primary electrochemical cells
PH27359A (en) * 1989-08-25 1993-06-21 Warner Lambert Co Process for cyclic amino acid anticonvulsant compounds

Also Published As

Publication number Publication date
IE62958B1 (en) 1995-03-08
DK212689D0 (da) 1989-05-01
DK175400B1 (da) 2004-09-27
EP0340677A2 (en) 1989-11-08
JPH0211546A (ja) 1990-01-16
FI892067A (fi) 1989-11-03
ATE101116T1 (de) 1994-02-15
EP0340677B1 (en) 1994-02-02
US4894476A (en) 1990-01-16
IE891142L (en) 1989-11-02
EP0340677A3 (en) 1990-12-27
DE68912819T2 (de) 1994-05-19
AU624130B2 (en) 1992-06-04
AU3267889A (en) 1989-11-02
ES2061774T3 (es) 1994-12-16
DK212689A (da) 1989-11-03
DE68912819D1 (de) 1994-03-17
CA1306755C (en) 1992-08-25
HK1000798A1 (en) 1998-05-01
JP2619951B2 (ja) 1997-06-11

Similar Documents

Publication Publication Date Title
FI892067A (fi) Gabapentinmonohydrat och foerfarande foer framstaellning daerav.
IT9083313A1 (it) Processo per la produzione di perossido di idrogeno (ii)
DE69403210D1 (de) Verfahren zur herstellung von n-acetylneuraminsäure
FI102165B (fi) Menetelmä monityydyttymättömien alifaattisten yhdisteiden puhdistamise ksi
PT545511E (pt) Processo para a preparacao de tetraazamacrociclos mono-n-substituidos
AU6592790A (en) Process for the synthesis of cyclic polynitrogenated compounds
DE69127222D1 (de) Verfahren zur Herstellung von Epoxyalkoholen von hoher optischer Reinheit
PT92726A (pt) Processo de eliminacao de etanol de bebidas produzidas por fermentacao
FR2693473B1 (fr) Procédé de préparation enzymatique d'hydrolysats de matières protéiques.
EP0348223A3 (en) Novel process for the preparation of serinol
DE69317820D1 (de) Verfahren zur Herstellung hochreiner Monoalkylphosphine
DE59307005D1 (de) Verfahren zur Herstellung von Ph3C[B(C6F5)4]
FI102083B (fi) Menetelmä L-karnitiinin valmistamiseksi epäjatkuvasti mikrobiologista tietä
IT8722452A0 (it) Processo per la sintesi di una n ndialchil idrossilammina.
IT1240869B (it) Processo per la produzione di perossido di idrogeno (i)
DE69120567D1 (de) Verfahren zur Herstellung von Fluormethyl-substituierter Piperidin-Carbodithioaten
ATE146472T1 (de) Umwandlungsverfahren von lorabef dihydrate in loracarbef monohydrate
EP0123301A3 (en) Photolithographic process for obtaining structures by the lift-off technique
DE69411660D1 (de) Vorrichtung zur Herstellung von Silizium-Einkristallen durch das Czochralski-Verfahren
FI890886A0 (fi) Kristallin n-(s-3-metylheptanoyl) -d-gamma-glutamyl-glycyl-d-alanin och foerfaranden foer dess framstaellning samt mellanprodukter.
EP0316964A3 (en) Process for the purification of podophyllotoxin
IT1228544B (it) Processo per la preparazione di dipeptidi
ATE66459T1 (de) Herstellungsverfahren von trifluormethylverbindungen.
OA08918A (fr) Procédé d'enrichissement de la canallite par flottation.
FR2697521B1 (fr) Procédé de synthèse du picolinate d'éthyle.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: WARNER-LAMBERT COMPANY